New hope for severe stroke patients with weakened immune systems
NCT ID NCT07202143
Summary
This study is testing whether adding a steroid medication (methylprednisolone) to the standard blood clot removal procedure helps people who have severe strokes with large brain damage and low immune cell counts. Researchers want to see if this combination treatment is at least as good as the standard procedure alone for helping patients survive and recover function 90 days after their stroke. The trial will enroll 200 adults across multiple hospitals who meet specific criteria for severe stroke.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LARGE INFARCT CORE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Neurology, the First Affiliated Hospital Fujian Medical University
RECRUITINGFuzhou, Fujian, 350005, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.